vTv Therapeutics Inc. Class A Common Stock (VTVT) is a publicly traded Healthcare sector company. As of July 16, 2026, VTVT trades at $32.49 with a market cap of $125.56M and a P/E ratio of 0.00. VTVT moved +1.00% today. Year to date, VTVT is -18.25%; over the trailing twelve months it is +125.60%. Its 52-week range spans $13.15 to $44.00. Analyst consensus is strong buy with an average price target of $56.83. Rallies surfaces VTVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VTVT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $32.49 |
| Market Cap | $125.56M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.00 |
| 52-Week Low | $13.15 |
| Volume | 123.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $36.84M |
| Net Income | $-729.00K |
| Gross Margin | 0.00% |
6 analysts cover VTVT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.83.